Injection sclerotherapy (n=77) | Octreotide (n=73) | |
Time from onset of bleed to admission to trial hospital (hours) | 5 (1–144) | 6 (0–125) |
Number of patients transferred from other hospitals | 28 (38%) | 35 (48%) |
Time from onset of bleed to start of treatment (hours) | 23 (2–63) | 19 (2–213) |
Time from admission to endoscopy to start of treatment (hours) | 5 (0–62) | 6 (0–163) |